FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297263727> ?p ?o ?g. }

• W4297263727 endingPage "18428" @default.
• W4297263727 startingPage "18419" @default.
• W4297263727 abstract "Surface modification with poly(ethylene glycol) (PEGylation) is an effective strategy to improve the colloidal stability of nanoparticles (NPs) and is often used to minimize cellular uptake and clearance of NPs by the immune system. However, PEGylation can also trigger the accelerated blood clearance (ABC) phenomenon, which is known to reduce the circulation time of PEGylated NPs. Herein, we report the engineering of stealth PEG NPs that can avoid the ABC phenomenon and, when modified with hyaluronic acid (HA), show specific cancer cell targeting and drug delivery. PEG NPs cross-linked with disulfide bonds are prepared by using zeolitic imidazolate framework-8 NPs as templates. The reported templating strategy enables the simultaneous removal of the template and formation of PEG NPs under mild conditions (pH 5.5 buffer). Compared to PEGylated liposomes, PEG NPs avoid the secretion of anti-PEG antibodies and the presence of anti-PEG IgM and IgG did not significantly accelerate the blood clearance of PEG NPs, indicating the inhibition of the ABC effect for the PEG NPs. Functionalization of the PEG NPs with HA affords PEG NPs that retain their stealth properties against macrophages, target CD44-expressed cancer cells and, when loaded with the anticancer drug doxorubicin, effectively inhibit tumor growth. The innovation of this study lies in the engineering of PEG NPs that can circumvent the ABC phenomenon and that can be functionalized for the improved and targeted delivery of drugs." @default.
• W4297263727 created "2022-09-28" @default.
• W4297263727 creator A5002083359 @default.
• W4297263727 creator A5010304528 @default.
• W4297263727 creator A5029577928 @default.
• W4297263727 creator A5032091517 @default.
• W4297263727 creator A5043839950 @default.
• W4297263727 creator A5050958352 @default.
• W4297263727 creator A5081628033 @default.
• W4297263727 creator A5090646299 @default.
• W4297263727 creator A5091087406 @default.
• W4297263727 date "2022-09-27" @default.
• W4297263727 modified "2023-10-17" @default.
• W4297263727 title "Engineering Poly(ethylene glycol) Nanoparticles for Accelerated Blood Clearance Inhibition and Targeted Drug Delivery" @default.
• W4297263727 cites W1843302206 @default.
• W4297263727 cites W1975088956 @default.
• W4297263727 cites W1977467418 @default.
• W4297263727 cites W2028893730 @default.
• W4297263727 cites W2033281188 @default.
• W4297263727 cites W2048576850 @default.
• W4297263727 cites W2091832363 @default.
• W4297263727 cites W2115824449 @default.
• W4297263727 cites W2133457317 @default.
• W4297263727 cites W2231813729 @default.
• W4297263727 cites W2257103983 @default.
• W4297263727 cites W2395806397 @default.
• W4297263727 cites W2401749584 @default.
• W4297263727 cites W2402319960 @default.
• W4297263727 cites W2472635460 @default.
• W4297263727 cites W2606439680 @default.
• W4297263727 cites W2807009021 @default.
• W4297263727 cites W2883113073 @default.
• W4297263727 cites W2888152746 @default.
• W4297263727 cites W2910335970 @default.
• W4297263727 cites W2920859500 @default.
• W4297263727 cites W2968488780 @default.
• W4297263727 cites W2971113245 @default.
• W4297263727 cites W2977948085 @default.
• W4297263727 cites W3041661068 @default.
• W4297263727 cites W3046633757 @default.
• W4297263727 cites W3048245695 @default.
• W4297263727 cites W3096686691 @default.
• W4297263727 cites W3128033077 @default.
• W4297263727 cites W3128713567 @default.
• W4297263727 cites W3161903464 @default.
• W4297263727 cites W3162871690 @default.
• W4297263727 cites W3188677010 @default.
• W4297263727 cites W3198884354 @default.
• W4297263727 cites W4200564506 @default.
• W4297263727 cites W4206224983 @default.
• W4297263727 cites W4223985272 @default.
• W4297263727 cites W4283641637 @default.
• W4297263727 doi "https://doi.org/10.1021/jacs.2c06877" @default.
• W4297263727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36166420" @default.
• W4297263727 hasPublicationYear "2022" @default.
• W4297263727 type Work @default.
• W4297263727 citedByCount "27" @default.
• W4297263727 countsByYear W42972637272023 @default.
• W4297263727 crossrefType "journal-article" @default.
• W4297263727 hasAuthorship W4297263727A5002083359 @default.
• W4297263727 hasAuthorship W4297263727A5010304528 @default.
• W4297263727 hasAuthorship W4297263727A5029577928 @default.
• W4297263727 hasAuthorship W4297263727A5032091517 @default.
• W4297263727 hasAuthorship W4297263727A5043839950 @default.
• W4297263727 hasAuthorship W4297263727A5050958352 @default.
• W4297263727 hasAuthorship W4297263727A5081628033 @default.
• W4297263727 hasAuthorship W4297263727A5090646299 @default.
• W4297263727 hasAuthorship W4297263727A5091087406 @default.
• W4297263727 hasConcept C10138342 @default.
• W4297263727 hasConcept C12554922 @default.
• W4297263727 hasConcept C155672457 @default.
• W4297263727 hasConcept C162324750 @default.
• W4297263727 hasConcept C171250308 @default.
• W4297263727 hasConcept C178790620 @default.
• W4297263727 hasConcept C18150654 @default.
• W4297263727 hasConcept C185154212 @default.
• W4297263727 hasConcept C185592680 @default.
• W4297263727 hasConcept C192562407 @default.
• W4297263727 hasConcept C21951064 @default.
• W4297263727 hasConcept C2776964284 @default.
• W4297263727 hasConcept C2777516009 @default.
• W4297263727 hasConcept C2779149719 @default.
• W4297263727 hasConcept C2779820397 @default.
• W4297263727 hasConcept C54400483 @default.
• W4297263727 hasConcept C55493867 @default.
• W4297263727 hasConcept C86803240 @default.
• W4297263727 hasConceptScore W4297263727C10138342 @default.
• W4297263727 hasConceptScore W4297263727C12554922 @default.
• W4297263727 hasConceptScore W4297263727C155672457 @default.
• W4297263727 hasConceptScore W4297263727C162324750 @default.
• W4297263727 hasConceptScore W4297263727C171250308 @default.
• W4297263727 hasConceptScore W4297263727C178790620 @default.
• W4297263727 hasConceptScore W4297263727C18150654 @default.
• W4297263727 hasConceptScore W4297263727C185154212 @default.
• W4297263727 hasConceptScore W4297263727C185592680 @default.
• W4297263727 hasConceptScore W4297263727C192562407 @default.
• W4297263727 hasConceptScore W4297263727C21951064 @default.
• W4297263727 hasConceptScore W4297263727C2776964284 @default.

• next